Kenneth Dickstein Selected Research

Biomarkers (Surrogate Marker)

1/2022	Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study.
1/2022	Biomarker changes as surrogate endpoints in early-phase trials in heart failure with reduced ejection fraction.
1/2022	Additional burden of iron deficiency in heart failure patients beyond the cardio-renal anaemia syndrome: findings from the BIOSTAT-CHF study.
1/2022	Pathophysiological pathways related to high plasma growth differentiation factor 15 concentrations in patients with heart failure.
1/2021	Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction.
1/2021	Neutrophil-to-lymphocyte ratio and outcomes in patients with new-onset or worsening heart failure with reduced and preserved ejection fraction.
1/2020	Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatment.
1/2019	The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study.
1/2019	Proenkephalin, an Opioid System Surrogate, as a Novel Comprehensive Renal Marker in Heart Failure.
11/2018	Comparing biomarker profiles of patients with heart failure: atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenneth Dickstein Research Topics

Disease

169	Heart Failure 10/2022 - 01/2001
39	Myocardial Infarction 01/2020 - 01/2001
15	Left Ventricular Dysfunction 01/2020 - 01/2001
12	Inflammation (Inflammations) 01/2022 - 06/2005
12	Atrial Fibrillation 01/2022 - 10/2007
11	Iron Deficiencies 01/2022 - 11/2009
8	Acute Coronary Syndrome 01/2022 - 12/2005
7	Type 2 Diabetes Mellitus (MODY) 01/2022 - 02/2006
7	Stroke (Strokes) 01/2019 - 09/2004
6	Cardiomyopathies (Cardiomyopathy) 01/2022 - 11/2005
6	Infarction (Infarctions) 01/2016 - 01/2001
5	Dyspnea (Shortness of Breath) 08/2020 - 02/2009
5	Hypotension (Low Blood Pressure) 01/2020 - 12/2012
4	Neoplasms (Cancer) 01/2022 - 11/2004
4	Chronic Renal Insufficiency 01/2022 - 11/2016
4	Necrosis 01/2022 - 11/2004
4	Diabetes Mellitus 01/2021 - 11/2006
4	Hypertension (High Blood Pressure) 10/2017 - 06/2003
3	Atherosclerosis 01/2020 - 06/2005
3	Heart Diseases (Heart Disease) 01/2020 - 06/2003
3	ST Elevation Myocardial Infarction 10/2017 - 05/2009
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2017 - 09/2004
3	Ventricular Remodeling 09/2013 - 11/2009
2	Mitral Valve Insufficiency (Mitral Regurgitation) 08/2022 - 01/2016
2	Pulmonary Hypertension 01/2022 - 01/2013
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2017
2	Bundle-Branch Block (Fascicular Block) 08/2021 - 08/2020
2	Disease Progression 01/2020 - 01/2017
2	Anemia 01/2019 - 12/2009
2	Edema (Dropsy) 01/2019 - 08/2009
2	Sudden Death 12/2018 - 03/2010

Drug/Important Bio-Agent (IBA)

24	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2021 - 09/2005
18	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2021 - 01/2001
17	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2012
13	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 05/2009
12	Angiotensin Receptor AntagonistsIBA 06/2021 - 01/2001
12	Losartan (Cozaar)FDA LinkGeneric 01/2018 - 01/2001
11	aliskiren FDA Link 08/2021 - 01/2011
10	Natriuretic PeptidesIBA 01/2022 - 09/2005
10	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2019 - 01/2001
8	CreatinineIBA 08/2021 - 09/2004
8	Captopril (Capoten)FDA LinkGeneric 06/2016 - 09/2002
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2019
6	IronIBA 11/2019 - 11/2009
6	Angiotensin IIIBA 01/2018 - 09/2002
6	ferric carboxymaltoseIBA 05/2016 - 11/2009
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 04/2002
5	Enalapril FDA LinkGeneric 08/2021 - 01/2011
5	TroponinIBA 01/2021 - 03/2010
5	Valsartan (Vals)FDA Link 01/2020 - 01/2001
5	C-Reactive ProteinIBA 11/2019 - 11/2005
5	CytokinesIBA 01/2018 - 04/2002
5	SodiumIBA 10/2017 - 11/2009
4	lixisenatideIBA 01/2022 - 05/2015
4	Growth Differentiation Factor 15IBA 01/2022 - 01/2012
4	Mineralocorticoid Receptor AntagonistsIBA 01/2021 - 10/2017
4	ReninIBA 01/2020 - 01/2011
3	Pharmaceutical PreparationsIBA 10/2022 - 01/2017
3	ChemokinesIBA 01/2022 - 11/2009
3	Fibroblast Growth Factor-23IBA 01/2022 - 01/2018
3	Serum AlbuminIBA 08/2021 - 11/2019
3	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2021 - 01/2018
3	AldosteroneIBA 01/2020 - 12/2012
3	Eplerenone (Inspra)FDA LinkGeneric 01/2020 - 09/2005
3	PotassiumIBA 01/2020 - 09/2014
3	Insulin (Novolin)FDA Link 04/2019 - 02/2006
3	Troponin IIBA 01/2018 - 11/2012
3	Troponin T (Troponin T1)IBA 01/2016 - 11/2009
3	Hemoglobins (Hemoglobin)IBA 12/2009 - 09/2007
3	Atrial Natriuretic Factor (ANF)IBA 08/2009 - 09/2005
3	Chromogranin AIBA 06/2008 - 01/2003
2	Lipocalin-2IBA 01/2022 - 05/2009
2	LigandsIBA 01/2022 - 06/2005
2	Sildenafil Citrate (Viagra)FDA Link 01/2022 - 01/2013
2	sacubitril and valsartan sodium hydrate drug combinationIBA 08/2021 - 01/2020
2	ChloridesIBA 08/2021 - 02/2017
2	HDL LipoproteinsIBA 01/2021 - 01/2018
2	ProteomeIBA 01/2021 - 01/2020
2	HDL CholesterolIBA 01/2021 - 01/2018
2	Carvedilol (Coreg)FDA LinkGeneric 01/2020 - 01/2018
2	AngiotensinsIBA 01/2020 - 06/2016
2	AdrenomedullinIBA 01/2019 - 06/2011
2	Biological ProductsIBA 01/2018 - 07/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 02/2006
2	Vasodilator Agents (Vasodilators)IBA 01/2017 - 07/2015
2	UlaritideIBA 01/2017 - 01/2017
2	Renin InhibitorsIBA 06/2016 - 04/2016
2	Prostaglandins AIBA 05/2016 - 11/2013
2	Neprilysin (Neutral Endopeptidase)IBA 10/2015 - 07/2004
2	NitrogenIBA 08/2015 - 09/2014
2	Urea (Carbamide)FDA LinkGeneric 08/2015 - 09/2014

Therapy/Procedure

42	Therapeutics 08/2022 - 03/2005
26	Cardiac Resynchronization Therapy 01/2022 - 10/2009
6	Percutaneous Coronary Intervention 10/2017 - 05/2009
3	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 10/2019 - 12/2008
3	Patient Readmission 08/2015 - 02/2009
3	Critical Care (Surgical Intensive Care) 05/2010 - 10/2008
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2019 - 03/2010
2	Defibrillators (Defibrillator) 01/2018 - 09/2011
2	Intravenous Infusions 01/2017 - 03/2016